Wonil Kim

Company: Aston Sci

Job title: Chief Scientific Officer

Bio:

Wonil Kim, Ph.D., is the Chief Scientific Officer at Aston Sci., where he leads the strategic development of innovative mRNA-based therapeutic and prophylactic vaccines, including the AI-driven Th-Vac® platform targeting cancer and infectious diseases. Wonil earned his Ph.D. in Molecular, Cellular, Developmental Biology, and Genetics from the University of Minnesota and has held prominent R&D leadership roles at GeneOne Life Science and Cyrus Therapeutics. His experience also includes serving as a staff scientist at St. Jude Children?s Research Hospital, focusing on drug screening and cancer biology. Dr. Kim?s expertise covers all aspects of mRNA-based drug development, solidifying his status as a key innovator in the field.